Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Aug 30, 2022

50715_rns_2022-08-30_5a722e46-4f4e-4a11-9794-29007fab8f0a.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

30 August 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description Nature of dealings Purchase Total Total amount Highest (H) Lowest (L)
of relevant / Sale number of paid / received prices paid prices paid
securities shares / received / received
involved
China International 29 August Ordinary Hedging as a result of the Purchase 2,100 $102,475.0000 $48.7976 $48.7976
Capital Corporation 2022 shares creation of new index-tracking
Limited ETFs where the relevant
securities represent less than
1% of the class in issue and
less than 20% of the value of
the securities in the basket or
index

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Ordinaryshares Disposal of the underlyingshares received from theredemption of pre-existingindex-tracking ETFs as aresult of unsolicited clientrequests Sale 2,100 $108,255.0000 $51.5500 $51.5500

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.